Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026)
Elanco Animal Health (ELAN) posted Amortization - Intangibles of $138.0 million for Q1 2026, down 0.72% sequentially from $139.0 million in Q4 2025, and up 7.81% YoY from $128.0 million in Q1 2025.
Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Amortization - Intangibles for 10 years, with the latest figure at $138.0 million in Q1 2026.
- Quarterly Amortization - Intangibles rose 7.81% year-over-year to $138.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $553.0 million (up 5.94% YoY) and the FY2025 annual result came in at $543.0 million, up 3.04% from the prior year.
- Amortization - Intangibles retreated to $138.0 million in Q1 2026 per ELAN's latest filing, from $139.0 million in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $140.0 million in Q3 2023 and troughed at $128.0 million in Q3 2022.
- A 5-year average of $134.4 million and a median of $134.0 million in 2023 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles fell 9.22% in 2022, then gained 9.38% in 2023.
- Over 5 years, Amortization - Intangibles stood at $130.0 million in 2022, then rose by 6.15% to $138.0 million in 2023, then fell by 5.8% to $130.0 million in 2024, then grew by 6.92% to $139.0 million in 2025, then retreated by 0.72% to $138.0 million in 2026.
- According to Business Quant data, Amortization - Intangibles over the past three periods registered $138.0 million, $139.0 million, and $140.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 139.00 Mn |
| Mar 31, 2026 | 138.00 Mn |
| Dec 31, 2025 | 139.00 Mn |
| Sep 30, 2025 | 140.00 Mn |
| Jun 30, 2025 | 136.00 Mn |
| Mar 31, 2025 | 128.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Sep 30, 2024 | 133.00 Mn |
| Jun 30, 2024 | 131.00 Mn |
| Mar 31, 2024 | 133.00 Mn |
| Dec 31, 2023 | 138.00 Mn |
| Sep 30, 2023 | 140.00 Mn |
| Jun 30, 2023 | 136.00 Mn |
| Mar 31, 2023 | 134.00 Mn |
| Dec 31, 2022 | 130.00 Mn |
| Sep 30, 2022 | 128.00 Mn |
| Jun 30, 2022 | 133.00 Mn |
| Mar 31, 2022 | 137.00 Mn |
| Dec 31, 2021 | 139.00 Mn |
| Sep 30, 2021 | 141.00 Mn |